What is the TAME Trial?
The Targeting Aging with Metformin (TAME) Trial is a series of nationwide, six-year clinical trials at 14 leading research institutions across the country that will engage over 3,000 individuals between the ages of 65-79.
Led
by AFAR Scientific Director Nir Barzilai, MD, these trials will test
whether those taking metformin experience delayed development or
progression of age-related chronic diseases—such as heart disease,
cancer, and dementia.
.webp)
.webp)
.png)
.png)
.png)
No comments:
Post a Comment